CAREFUSION CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-08-31: Reporting owner Stafslien Joan; Form 4; Security Stock options (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-08-30: Reporting owner Hinrichs James F.; Form 4; Security Stock options (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-08-28: Reporting owner Maschal Jean; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-08-15: Reporting owner Gallahue Kieran; Form 4; Security Options (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-08-31 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −621 0 owned after | $17.77 exercise price | 2012-09-04 | |
| 2012-08-30 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −703 0 owned after | $17.77 exercise price | 2012-09-04 | |
| 2012-08-28 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −444 0 owned after | $17.77 exercise price | 2012-08-30 | |
| 2012-08-15 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +478,392 478,392 owned after | $26.79 exercise price | 2012-08-16 | |
| 2012-08-15 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,070 69,070 owned after | $26.79 exercise price | 2012-08-16 | |
| 2012-08-15 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,750 26,750 owned after | $26.79 exercise price | 2012-08-16 | |
| 2012-08-15 | MARCHETTI ROGER Officer (EVP, Human Resources) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +49,931 49,931 owned after | $26.79 exercise price | 2012-08-16 | |
| 2012-08-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +92,596 92,596 owned after | $26.79 exercise price | 2012-08-16 | |
| 2012-08-15 | La Fortune Gordon Officer (EVP, EMEA/APAC Commercial Ops) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,926 45,926 owned after | $26.79 exercise price | 2012-08-16 | |
| 2012-08-15 | Jain Vivek Officer (Pres., Procedural Solutions) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +84,013 84,013 owned after | $26.79 exercise price | 2012-08-16 | |
| 2012-08-15 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,759 37,759 owned after | $26.79 exercise price | 2012-08-16 | |
| 2012-08-15 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +156,826 156,826 owned after | $26.79 exercise price | 2012-08-16 |